Oticon Zeal vs Resound Vivia 9 60S microRIE

The Oticon Zeal is a premium invisible-in-ear prescription hearing aid priced at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.7/5, placing it in the top 11% of prescription hearing aids tested and ranking #5 of 36 devices in its category. Speech performance is where the Zeal truly excels. It achieved an excellent 4.9/5 in speech-in-quiet testing, scoring 1.56 points above the category average—among the strongest results we've measured. Speech-in-noise performance is solid at 3.0/5, which is 1.08 points above the category average of 1.96/5, making it notably better than typical prescription aids in challenging listening environments. Music streaming quality scores 3.3/5, sitting 0.66 points above category average and providing solid fidelity for phone audio. However, the Zeal shows some limitations in other areas. Own-voice comfort is mixed at 2.0/5, falling 0.75 points below the category average—users sensitive to how their own voice sounds may notice this. Feedback handling, while solid in absolute terms at 3.3/5, measures 1.41 points below the category average of 4.71/5. The Zeal is best suited for users who prioritize outstanding speech clarity in both quiet and moderately noisy settings, and who value quality audio streaming. Those particularly sensitive to own-voice perception or who need maximum feedback stability may want to discuss these tradeoffs with their hearing care provider.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.